Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare, Eli Lilly
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on Wednesday, citing the Centers for Medicare & Medicaid Services.
Lilly Wins Medicare Coverage for Zepbound in Sleep Apnea
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to secure CMS coverage for obesity drugs.
Medicare Expands Coverage of Eli Lilly’s Weight-Loss Drug
Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.
1h
on MSN
Novo, Eli Lilly to dominate global pharma sales in 2025: report
Blockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) lead Evaluate Pharma’s list of ...
1h
on MSN
Exclusive: Arianna Huffington’s Thrive Global inks novel partnership with pharma giant Eli Lilly
Good morning! Meta's elimination of fact-checking opens the door to misogynistic speech, Jane Fraser faces a test at Citi, ...
31m
Thrive Global Works with Eli Lilly and Company to Offer Healthy Behaviors Tools and Resources to Improve Health Outcomes
Thrive Global announced today it is working with Eli Lilly and Company to embed behavior change tools and resources onto LillyDirect and into traditional Lilly consumer channels in order to complement ...
1d
Eli Lilly & Co. stock underperforms Tuesday when compared to competitors despite daily gains
Eli Lilly & Co. closed $199.24 short of its 52-week high ($972.53), which the company achieved on August 22nd.
55m
US pharma major Eli Lilly to establish second Indian GCC in Hyderabad
The GCC, to be known as the Lilly Capability Centre India (LCCI), will be the company’s second centre in the country, ...
4h
Eli Lilly and Company to set-up global capability centre in Hyderabad, to recruit over 1,000 skilled workers
The company said that it would be recruiting more than a 1,000 highly-skilled team members to strengthen its digital strategy ...
17h
on MSN
Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
ndtvprofit
4h
Eli Lilly To Create New Global Capability Centre In Hyderabad, Hire 1,000 People
The company further said it plans to employ around 1,000 to 1,500 highly-skilled professionals including technology engineers ...
2d
Eli Lilly's Options: A Look at What the Big Money is Thinking
Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. And retail traders should know. We ...
7h
Eli Lilly to launch new capability centre in Hyderabad, hiring over 1,000 skilled professionals
Eli Lilly establishes new global capability centre in Hyderabad, recruiting over 1,000 skilled team members for digital ...
2h
on MSN
Flynn: Eli Lilly could capture a significant part of a $100 billion market with Zepbound.
Terence Flynn, Biotech Analyst at Morgan Stanley, discusses Eli Lilly's recent stock boost and its designation as Morgan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Zepbound
New York Stock Exchange
Novo Nordisk
S&P 500 Index
Trade
Feedback